Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BI-836826

Catalog No. T9901A-1692 Copy Product Info
🥰Excellent
BI-836826 is a chimeric IgG1 anti-CD37 monoclonal antibody with an engineered Fc fragment. It exhibits both antibody-dependent cellular cytotoxicity (ADCC) and direct pro-apoptotic activity. BI-836826 is applicable in research related to chronic lymphocytic leukemia.

BI-836826

Copy Product Info
🥰Excellent
Catalog No. T9901A-1692

BI-836826 is a chimeric IgG1 anti-CD37 monoclonal antibody with an engineered Fc fragment. It exhibits both antibody-dependent cellular cytotoxicity (ADCC) and direct pro-apoptotic activity. BI-836826 is applicable in research related to chronic lymphocytic leukemia.

BI-836826
Cas No. 2235420-23-0
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
BI-836826 is a chimeric IgG1 anti-CD37 monoclonal antibody with an engineered Fc fragment. It exhibits both antibody-dependent cellular cytotoxicity (ADCC) and direct pro-apoptotic activity. BI-836826 is applicable in research related to chronic lymphocytic leukemia.
Chemical Properties
Cas No.2235420-23-0
Storage & Solubility Information
StorageStore at -20°C Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy BI-836826 | purchase BI-836826 | BI-836826 cost | order BI-836826